Literature DB >> 2685709

Procoagulant effects of intraocular sodium hyaluronate (Healon) after phakic diabetic vitrectomy. A prospective, randomized study.

A J Packer1, B W McCuen, W L Hutton, R C Ramsay.   

Abstract

A procoagulant effect was reported previously after injection of 0.50 to 0.75 ml of sodium hyaluronate (Healon) into the vitreous cavity at the end of phakic diabetic vitrectomies. A multicenter, randomized, prospective trial was done to study this effect. In the treatment group the media was clear in 50% of eyes in the immediate postoperative period compared with only 8% in the control group. At 2 to 6 weeks, there was no statistically significant difference between the two groups. The authors conclude that such sodium hyaluronate injection provides clear media in a significant number of eyes in the immediate postoperative period, potentially allowing thorough postoperative evaluation and early retinal photocoagulation if needed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2685709     DOI: 10.1016/s0161-6420(89)32686-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial.

Authors:  A R Ramezani; H Ahmadieh; A K Ghaseminejad; S Yazdani; B Golestan
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

2.  Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy.

Authors:  Ashraf M El-Batarny
Journal:  Clin Ophthalmol       Date:  2008-12

3.  Sulfur Hexafluoride 20% versus Lactated Ringer's Solution for Prevention of Early Postoperative Vitreous Hemorrhage after Diabetic Vitrectomy.

Authors:  Fereydoun Farrahi; Mostafa Feghhi; Biuk Bagherzadeh; Mahmood Latifi
Journal:  J Ophthalmic Vis Res       Date:  2010-04

4.  The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy.

Authors:  Abdullah Al-Kharashi; Tural Galbinur; Efrem D Mandelcorn; Rajeev H Muni; Mir Nabavi; Peter J Kertes
Journal:  Saudi J Ophthalmol       Date:  2016-10-29

Review 5.  Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.

Authors:  Jonathan M Smith; David H W Steel
Journal:  Cochrane Database Syst Rev       Date:  2015-08-07

6.  Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.

Authors:  Xin-Yu Zhao; Song Xia; You-Xin Chen
Journal:  Br J Ophthalmol       Date:  2017-12-15       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.